Skip to main content
2023 IKCS: Europe Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Gabriel Malouf, MD, PhD

Institut de Cancérologie de Strasbourg-Europe, Strasbourg University, France

Professor Gabriel Malouf is a physician-scientist, consultant in genitourinary medical oncology at the Institut de Cancérologie de Strasbourg and researcher at the Institute of Genetics and Molecular and Cellular Biology (Illkirch, France)

Gabriel Malouf is board certified in medical oncology (2012) and obtained a PhD in cancer epigenetics (2014). After a postdoctoral fellowship in MD Anderson Cancer Center (TX, USA), he was appointed as Chef de Clinique at the Sorbonne University before undertaking a full professor position at Strasbourg University in 2018. Gabriel Malouf leadership, training, clinical, translational and basic science expertise are mainly dedicated to studying the molecular underpinnings of rare kidney cancers. He is currently the national French coordinator of the rare kidney cancer group. During last decade, he generated extensive integrative profiling of several rare kidney cancers such as medullary carcinomas and translocation renal cell carcinomas. In addition, he had reported seminal works on the role of long-non coding RNA and epigenetic alterations in kidney cancers. Gabriel Malouf is currently developing a dedicated translational research program focusing on precision medicine of rare kidney cancers, including the generation of genetically engineered mice and investigating tumor heterogeneity using single-cell sequencing approaches. He has a proven publication records in top-tier cancer journals (i.e. Cancer Cell, Genome Biology, Cancer Research, European Urology…) while maintaining clinical care allowing him to be at the intersection of clinic and biology. He is editor for a book on rare kidney cancer.

Gabriel Malouf is often part of the faculty of the major genitourinary meetings and is currently associate editor of Clinical Genitourinary Cancer. He is also member of the steering committee of EIKCS.

Disclosure information not submitted.

Presentation(s):